Hanny T Al-Samkari

108PUBLICATIONS
174CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (108)

|Oct 26, 2026
Circulating Biomarkers Associated With Hereditary Hemorrhagic Telangiectasia Sensitive to ALK1 Modulation.

|Aug 16, 2026
Effect of efgartigimod IV on immature platelet fraction in primary immune thrombocytopenia in the ADVANCE IV trial.

|Aug 04, 2026
Systemic Bevacizumab for Severe Bleeding From Acquired Gastrointestinal Vascular Malformations.

|Jul 13, 2026
Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial.

|Jul 06, 2026
How I treat chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists.

|Jun 08, 2026
A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders.

Pageof 18

Frequent Collaborators

10 joint publications

Rachael F Grace

9 joint publications

Andrew Song

6 joint publications

Kevin H M Kuo

6 joint publications

Vivek N Iyer